| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.44 |
3e-15 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
7e-15 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
8e-13 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.48 |
9e-13 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
1e-10 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
2e-10 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.45 |
1e-09 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-09 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-09 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.41 |
7e-09 |